Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
To estimate the evolution of height and growth rate over 5 years of growth hormone (GH)
treatment To estimate the prognostic factors of growth rate with GH treatment To confirm the
good clinical and biological safety of GH treatment in such children